Search results
Small Business - Cordele Dispatch | Cordele Dispatch
Cordele Dispatch· 7 days agoFlamingo Therapeutics Presents Poster at ASCO 2024 on Phase II PEMDA-HN Trial for Head and Neck Squamous Cell Carcinoma (HNSCC) PR Newswire ...
Enspectra receives breakthrough status for AI-powered skin imaging platform
Medical Device Network via Yahoo Finance· 3 days agoThe imaging platform is aimed at evaluating lesions indicative of basal cell carcinoma (BCC) and ...
..., in Checkpoint Inhibitor Resistant Advanced Merkel Cell Carcinoma (MCC) and Cutaneous Squamous ...
Morningstar· 6 days agoTAMPA, FL and SAN DIEGO, CA / ACCESSWIRE / June 3, 2024 / TuHURA Biosciences, Inc. ("TuHURA"), a Phase 3 registration-stage immune-oncology company developing novel technologies to overcome ...
3 Reasons to Buy Moderna Stock
Motley Fool via Yahoo Finance· 23 hours agoIt will take a bit longer before mRNA-4157 earns approval; it will need to ace pivotal studies first. However, there's no denying that it would be an...
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 2 days agoThe companies are also testing the combo in patients with melanoma, non-small cell lung cancer,...
What To Know About Personalized mRNA Cancer Vaccines After Promising Trials From Moderna And Merck
Forbes· 5 days agoCancer vaccines are finally showing promise as Moderna and Merck touted promising data on an...
EMA CHMP supports CStone’s sugemalimab for metastatic NSCLC
Pharmaceutical Technology via Yahoo Finance· 6 days agoIn China, the National Medical Products Administration (NMPA) has approved sugemalimab for stage III...
How to Spot Skin Cancer on the Scalp (Hint: Your Hair Stylist Can Help) + 4 Ways To Cut Your Risk
Woman's World via Yahoo News· 6 days agoBasal cell carcinoma may look like a pink or fleshy bump, while squamous cell carcinoma typically...
Transplant in Unresectable Colorectal Liver Metastases?
Medscape· 3 days agoLiver transplant plus chemotherapy offers a potential cure for carefully selected patients with...
Moderna, Merck Reveal Three Year Data For Individualized Cancer Therapy In High-Risk Melanoma...
Benzinga via Yahoo Finance· 6 days agoMonday, Moderna Inc (NASDAQ:MRNA) and Merck & Co Inc (NYSE:MRK) announced the first presentation of...
